Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor
Clinical trial NCT03884972 · WITHDRAWN
Trial details
- NCT number
- NCT03884972
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-18
- Primary completion
- 2020-03-04
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.